Status:

NOT_YET_RECRUITING

Gut Microbiome in People Living With HIV and HBV

Lead Sponsor:

Kangbuk Samsung Hospital

Collaborating Sponsors:

Kyunghee University Medical Center

Hanyang University

Conditions:

Human Immunodeficiency Virus

Chronic Hepatitis b

Eligibility:

All Genders

19+ years

Brief Summary

Building a Microbiome Data Platform and Conducting Clinical Evidence Research in Individuals Infected with the Human Immunodeficiency Virus (HIV) and Hepatitis B virus.

Detailed Description

Chronic HIV infection, which often results in metabolic disorders, leads to shifts in the gut microbiota, contributing to immune activation and chronic inflammation. This study seeks to compare the gu...

Eligibility Criteria

Inclusion

  • HIV patients
  • Inidividuals over 19 years old
  • HIV patients on antiretroviral therapy (ART)
  • HBV patients
  • Individuals over 19 years old
  • Chronic hepatitis B patients with either chronic hepatitis, liver cirrhosis or hepatocellular carcinoma

Exclusion

  • Patients with indeterminate colitis
  • Individuals who have used antibiotics or steroids within 24 hours of the microbiome sample collection (excluding antiviral treatments for hepatitis B and HIV)
  • Individuals who have used vaginal or external medications, including antifungal agents, within 24 hours of microbiome sample collection
  • Those with acute illnesses, with or without fever, of moderate or severe severity; however, sampling may be postponed until the subject recovers.
  • Individuals with gastrointestinal disorders that may impact microbiome analysis and are currently medically uncontrolled or under treatment for the respective condition
  • Individuals with a positive result in a urine pregnancy test, pregnant, or breastfeeding at the time of microbiome sample collection
  • Individuals for whom medical opinions suspect that they may have an impact on the sample collection at the time of microbiome collection.

Key Trial Info

Start Date :

November 27 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT06130137

Start Date

November 27 2023

End Date

December 31 2027

Last Update

November 14 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.